Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| PHARVARIS N V COM | 4,639,304 | 4,643,430 | +4,126 | $131.06M | $160.57M | 30.92% | +$29.51M |
| PARABILIS MEDICINES INC | 0 | 5,266,697 | +5,266,697 | $0 | $144.15M | 27.75% | +$144.15M |
| ALUMIS INC | 4,528,408 | 4,528,408 | 0 | $99.76M | $127.43M | 24.53% | +$27.67M |
| ACHIEVE LIFE SCIENCE INC | 0 | 5,914,720 | +5,914,720 | $0 | $38.62M | 7.44% | +$38.62M |
| ALX ONCOLOGY HLDGS INC | 12,884,638 | 12,884,638 | 0 | $25.83M | $26.67M | 5.14% | +$837.5K |
| Harmony Biosciences Holdings, Inc.(HRMY) | 489,194 | 472,194 | -17,000 | $13.70M | $17.19M | 3.31% | +$3.49M |
| LYELL IMMUNOPHARMA INC | 337,697 | 337,697 | 0 | $6.77M | $4.74M | 0.91% | -$2.03M |
| ARTIVA BIOTHERAPEUTICS INC | 531,337 | 0 | -531,337 | $3.42M | $0 | — | -$3.42M |